ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED
Clinical trials for ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat leukemia: multiple drug cocktails tested
Disease control Recruiting nowThis phase II trial tests several experimental drug combinations against the standard treatment for high-risk acute myeloid leukemia (AML) in patients aged 59 or younger. The goal is to see if newer regimens, including venetoclax and liposome formulations, can better shrink cance…
Matched conditions: ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New screening trial aims to speed up matching of cancer patients to the right treatments
Knowledge-focused Recruiting nowThis study tests a new way to screen patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) by analyzing their bone marrow and blood for specific biomarkers. The goal is to quickly match patients with a treatment trial that targets their cancer's unique mark…
Matched conditions: ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC